MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on November 10, 2004; DOI: 10.1124/mol.104.007138


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.104.007138v1
67/2/545    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Author home page(s):
Gary D Kruh
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, Z.-S.
Right arrow Articles by Kruh, G. D
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, Z.-S.
Right arrow Articles by Kruh, G. D


Received for publication September 14, 2004.
Revised November 5, 2004.
Accepted for publication November 8, 2004.

Transport of Bile Acids, Sulfated Steroids, Estradiol 17-{beta}-D-Glucuronide and Leukotriene C4 by Human Multidrug Resistance Protein 8 (ABCC11): STIMULATION OF ESTRADIOL 17-{beta}-D-GLUCURONIDE TRANSPORT BY DEHYDROEPIANDROSTERONE 3-SULFATE

Zhe-Sheng Chen 1, Yanping Guo 1, Martin G Belinsky 1, Elena Kotova 1, Gary D Kruh 1*

1 Fox Chase Cancer Center

* Address correspondence to: E-mail: gd_kruh{at}fccc.edu

Abstract

We previously determined that expression of human MRP8, a recently described member of the MRP family of ATP-binding cassette transporters, enhances cellular extrusion of cyclic nucleotides and confers resistance to nucleotide analogs (Guo, Y. et al., J Biol Chem, 278, 29509-14, 2003). However, the in vitro transport characteristics of the pump have not been determined. Here, the substrate selectivity and biochemical activity of MRP8 is investigated using membrane vesicles prepared from LLC-PK1 cells transfected with MRP8 expression vector. Expression of MRP8 is shown to stimulate the ATP-dependent uptake of a range of physiological and synthetic lipophilic anions, including the glutathione S-conjugates leukotriene C4 and dinitrophenyl S-glutathione, steroid sulfates such as dehydroepiandrosterone 3-sulfate (DHEAS) and estrone 3-sulfate, glucuronides such as estradiol 17-{beta}-D-glucuronide (E217{beta}G), the monoanionic bile acids glycocholate and taurocholate, and methotrexate. In addition, MRP8 is competent in the in vitro transport of cAMP and cGMP, in accord with the results of our previously reported cellular studies. DHEAS, E217{beta}G and methotrexate were transported with Km and Vmax values of 13.0 ± 0.8 µM and 34.9 ± 9.5 pmol/mg/min, 62.9 ± 12 µM and 62.0 ± 5.2 pmol/mg/min and 957 ± 28 µM and 317 ± 17 pmol/mg/min, respectively. Based upon the stimulatory action of DHEAS on uptake of E217{beta}G, the attenuation of this effect at high DHEAS concentrations and the lack of reciprocal promotion of DHEAS uptake by E217{beta}G, a model involving nonreciprocal constructive interactions between some transport substrates is invoked. These results suggest that MRP8 is involved in physiological processes involving bile acids, conjugated steroids and cyclic nucleotides and indicate that the pump has complex interactions with its substrates.


Key words: Sex hormones, cAMP, cGMP, Nucleoside/Nucleotide, MDR/p-Glycoprotein, Organic anion, Glutathione, Leukotrienes, Resistance





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics